Hansville, WA, United States of America

Meir Strahilevitz

This inventor holds 15 USPTO granted patents. Top assignee: Other. Active years: 1983-2007.


% Patents Active = 93.3

Average Co-Inventor Count = 1.0

ph-index = 11

Forward Citations = 428(Granted Patents)


Location History:

  • Houston, TX (US) (1991)
  • Creve Coeur, MO (US) (1989 - 1998)
  • Seattle, WA (US) (1983 - 2003)
  • Hansville, WA (US) (1998 - 2007)

Company Filing History:

goldMedal15 out of 834,411 
Other
 patents

Years Active: 1983-2007

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Meir Strahilevitz

Introduction

Meir Strahilevitz is a prominent inventor based in Hansville, WA (US), known for his significant contributions to the field of medical technology. With a total of 15 patents to his name, he has focused on developing advanced methods for cancer treatment and diagnostic visualization. His work aims to improve patient outcomes through innovative therapeutic techniques.

Latest Patents

Strahilevitz's latest patents include groundbreaking methods of treatment and diagnostic visualization, particularly in cancer. These patents detail methods and reagents for improved treatment and diagnostic imaging, specifically targeting tumors or specific organs and tissues. The techniques utilize specific targeting of treatment and imaging ligands, enhancing the effectiveness of cancer therapies. His inventions include hybrid targeting molecules, which combine binding sites for both the target and the treatment or visualization ligand. This innovative approach allows for increased concentration of therapeutic agents in tumors while minimizing toxicity to the rest of the body. Additionally, his methods provide improved visualization of cancer by concentrating imaging ligands in the cancerous tissues and reducing their presence in normal tissues.

Career Highlights

Throughout his career, Strahilevitz has made significant strides in the medical field, particularly in the treatment of atherosclerosis, cancer, degenerative, and autoimmune diseases. His extracorporeal affinity adsorption methods have proven effective in removing compounds that contribute to disease pathogenesis. These methods offer promising therapeutic interventions, enhancing the efficacy of treatments for various conditions.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Meir Strahilevitz's innovative work in cancer treatment and diagnostic visualization showcases his dedication to advancing medical technology. His patents reflect a commitment to improving patient care through targeted therapies and enhanced diagnostic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…